BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial 2009;22:636-43. [PMID: 20017834 DOI: 10.1111/j.1525-139X.2009.00659.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Iwasaki Y, Kazama JJ, Fukagawa M. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. Biomed Res Int 2017;2017:3485785. [PMID: 28421193 DOI: 10.1155/2017/3485785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
2 Bronas UG, Puzantian H, Hannan M. Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise. Biomed Res Int 2017;2017:2726369. [PMID: 28503567 DOI: 10.1155/2017/2726369] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
3 Ahmed H, Farewell D, Francis NA, Paranjothy S, Butler CC. Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data. PLoS Med 2018;15:e1002652. [PMID: 30199555 DOI: 10.1371/journal.pmed.1002652] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lin S, Luan X, He W, Ruan Y, Yuan C, Fan A, Chen X, He J. Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort. Neuropsychiatr Dis Treat 2020;16:201-8. [PMID: 32021214 DOI: 10.2147/NDT.S225905] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mohammed CJ, Xie Y, Brewster PS, Ghosh S, Dube P, Sarsour T, Kleinhenz AL, Crawford EL, Malhotra D, James RW, Kalra PA, Haller ST, Kennedy DJ. Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease. J Clin Med 2019;8:E1034. [PMID: 31311140 DOI: 10.3390/jcm8071034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ishigami J, Grams ME, Chang AR, Carrero JJ, Coresh J, Matsushita K. CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2017;69:752-61. [PMID: 27884474 DOI: 10.1053/j.ajkd.2016.09.018] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 9.2] [Reference Citation Analysis]
7 Baylis C. Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens 2012;21:1-6. [PMID: 22048724 DOI: 10.1097/MNH.0b013e32834d54ca] [Cited by in Crossref: 84] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
8 Colombo G, Reggiani F, Cucchiari D, Astori E, Garavaglia ML, Portinaro NM, Saino N, Finazzi S, Milzani A, Badalamenti S, Dalle-Donne I. Plasma Protein Carbonylation in Haemodialysed Patients: Focus on Diabetes and Gender. Oxid Med Cell Longev 2018;2018:4149681. [PMID: 30057679 DOI: 10.1155/2018/4149681] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
9 Chang MC, Chang HH, Chan CP, Yeung SY, Hsien HC, Lin BR, Yeh CY, Tseng WY, Tseng SK, Jeng JH. p-Cresol affects reactive oxygen species generation, cell cycle arrest, cytotoxicity and inflammation/atherosclerosis-related modulators production in endothelial cells and mononuclear cells. PLoS One 2014;9:e114446. [PMID: 25517907 DOI: 10.1371/journal.pone.0114446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
10 Gamboa JL, Pretorius M, Todd-Tzanetos DR, Luther JM, Yu C, Ikizler TA, Brown NJ. Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis. J Am Soc Nephrol 2012;23:334-42. [PMID: 22158433 DOI: 10.1681/ASN.2011030287] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
11 Dimitrijevic ZM, Salinger Martinovic SS, Nikolic VN, Cvetkovic TP. Protein Carbonyl Content Is a Predictive Biomarker of Eccentric Left Ventricular Hypertrophy in Hemodialysis Patients. Diagnostics (Basel) 2019;9:E202. [PMID: 31775390 DOI: 10.3390/diagnostics9040202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Granata S, Dalla Gassa A, Bellin G, Lupo A, Zaza G. Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. Biomed Res Int 2016;2016:9290857. [PMID: 27419142 DOI: 10.1155/2016/9290857] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
13 Kennedy DJ, Tang WH, Fan Y, Wu Y, Mann S, Pepoy M, Hazen SL. Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease. J Am Heart Assoc 2013;2:e000104. [PMID: 23557751 DOI: 10.1161/JAHA.112.000104] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
14 Torramade-Moix S, Palomo M, Vera M, Jerez D, Moreno-Castaño AB, Zafar MU, Rovira J, Diekmann F, Garcia-Pagan JC, Escolar G, Cases A, Diaz-Ricart M. Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia. Cardiovasc Drugs Ther 2021;35:521-32. [PMID: 32651897 DOI: 10.1007/s10557-020-07010-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zager RA, Johnson AC, Becker K. Plasma and urinary heme oxygenase-1 in AKI. J Am Soc Nephrol 2012;23:1048-57. [PMID: 22440905 DOI: 10.1681/ASN.2011121147] [Cited by in Crossref: 72] [Cited by in F6Publishing: 50] [Article Influence: 7.2] [Reference Citation Analysis]
16 Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation 2012;126:2293-301. [PMID: 23032326 DOI: 10.1161/CIRCULATIONAHA.112.099606] [Cited by in Crossref: 64] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
17 Meyer TW, Hostetter TH. Approaches to uremia. J Am Soc Nephrol 2014;25:2151-8. [PMID: 24812163 DOI: 10.1681/ASN.2013121264] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
18 Jhee JH, Lee E, Cha MU, Lee M, Kim H, Park S, Yun HR, Jung SY, Kee YK, Yoon CY, Han SH, Yoo TH, Kang SW, Park JT. Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease. Medicine (Baltimore) 2017;96:e8476. [PMID: 29095304 DOI: 10.1097/MD.0000000000008476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
19 Rusu CC, Racasan S, Kacso IM, Moldovan D, Potra A, Patiu IM, Vladutiu D, Caprioara MG. Malondialdehyde can predict survival in hemodialysis patients. Clujul Med 2016;89:250-6. [PMID: 27152077 DOI: 10.15386/cjmed-537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
20 Kisic B, Miric D, Dragojevic I, Rasic J, Popovic L. Role of Myeloperoxidase in Patients with Chronic Kidney Disease. Oxid Med Cell Longev 2016;2016:1069743. [PMID: 27127544 DOI: 10.1155/2016/1069743] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
21 Günal SY, Ustündağ B, Günal Aİ. The assessment of oxidative stress on patients with chronic renal failure at different stages and on dialysis patients receiving different hypertensive treatment. Indian J Clin Biochem 2013;28:390-5. [PMID: 24426242 DOI: 10.1007/s12291-013-0316-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
22 Sumida K, Yamagata K, Kovesdy CP. Constipation in CKD. Kidney Int Rep 2020;5:121-34. [PMID: 32043026 DOI: 10.1016/j.ekir.2019.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
23 Yan G, Tang C, Ma G. The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction. Int J Gen Med 2021;14:1621-9. [PMID: 33958892 DOI: 10.2147/IJGM.S303678] [Reference Citation Analysis]
24 Cvetković T, Veličković-Radovanović R, Stojanović D, Stefanović N, Ignjatović A, Stojanović I, Sladojević N, Pavlović D. Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol - Differences or Similarities? J Med Biochem 2015;34:295-303. [PMID: 28356840 DOI: 10.2478/jomb-2014-0047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
25 Paul K, Kretzschmar D, Yilmaz A, Bärthlein B, Titze S, Wolf G, Busch M; GCKD-Study Investigators. Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study. BMC Nephrol 2013;14:274. [PMID: 24325304 DOI: 10.1186/1471-2369-14-274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
26 Sung CC, Hsu YC, Chen CC, Lin YF, Wu CC. Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Oxid Med Cell Longev 2013;2013:301982. [PMID: 24058721 DOI: 10.1155/2013/301982] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
27 Movahhed SMM. Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1599-611. [PMID: 34097094 DOI: 10.1007/s00210-021-02099-x] [Reference Citation Analysis]
28 Sandeman SR, Howell CA, Phillips GJ, Zheng Y, Standen G, Pletzenauer R, Davenport A, Basnayake K, Boyd O, Holt S, Mikhalovsky SV. An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med 2014;25:1589-97. [PMID: 24573455 DOI: 10.1007/s10856-014-5173-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
29 McManus DD, Saczynski JS, Ward JA, Jaggi K, Bourrell P, Darling C, Goldberg RJ. The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic. J Atr Fibrillation. 2012;5:442. [PMID: 28496745 DOI: 10.4022/jafib.442] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Kuo IC, Lee JJ, Hwang DY, Lim LM, Lin HY, Hwang SJ, Chen HC, Hung CC. Pyuria, urinary tract infection and renal outcome in patients with chronic kidney disease stage 3-5. Sci Rep 2020;10:19460. [PMID: 33173137 DOI: 10.1038/s41598-020-76520-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
32 Stinghen AE, Pecoits-Filho R. Vascular damage in kidney disease: beyond hypertension. Int J Hypertens 2011;2011:232683. [PMID: 21876786 DOI: 10.4061/2011/232683] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
33 Reiterer C, Hu K, Sljivic S, Falkner von Sonnenburg M, Fleischmann E, Kabon B. The effect of mannitol on oxidation-reduction potential in patients undergoing deceased donor renal transplantation-A randomized controlled trial. Acta Anaesthesiol Scand 2021;65:162-8. [PMID: 32966587 DOI: 10.1111/aas.13713] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol 2019;23:437-47. [PMID: 30178234 DOI: 10.1007/s10157-018-1641-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
35 Akimoto T, Morishita Y, Ito C, Iimura O, Tsunematsu S, Watanabe Y, Kusano E, Nagata D. Febuxostat for hyperuricemia in patients with advanced chronic kidney disease. Drug Target Insights 2014;8:39-43. [PMID: 25210423 DOI: 10.4137/DTI.S16524] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
36 Gamboa JL, Roshanravan B, Towse T, Keller CA, Falck AM, Yu C, Frontera WR, Brown NJ, Ikizler TA. Skeletal Muscle Mitochondrial Dysfunction Is Present in Patients with CKD before Initiation of Maintenance Hemodialysis. Clin J Am Soc Nephrol 2020;15:926-36. [PMID: 32591419 DOI: 10.2215/CJN.10320819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
37 Xu H, Gasparini A, Ishigami J, Mzayen K, Su G, Barany P, Ärnlöv J, Lindholm B, Elinder CG, Matsushita K, Carrero JJ. eGFR and the Risk of Community-Acquired Infections. Clin J Am Soc Nephrol 2017;12:1399-408. [PMID: 28818849 DOI: 10.2215/CJN.00250117] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 5.4] [Reference Citation Analysis]
38 Gamboa JL, Pretorius M, Sprinkel KC, Brown NJ, Ikizler TA. Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study. BMC Nephrol 2015;16:167. [PMID: 26494370 DOI: 10.1186/s12882-015-0162-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
39 Santos PR. Evaluation of objective and subjective indicators of death in a period of one year in a sample of prevalent patients under regular hemodialysis. BMC Res Notes 2012;5:24. [PMID: 22236399 DOI: 10.1186/1756-0500-5-24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
40 Paul K, Franke S, Nadal J, Schmid M, Yilmaz A, Kretzschmar D, Bärthlein B, Titze S, Koettgen A, Wolf G, Busch M; GCKD study group. Inflammation, vitamin D and dendritic cell precursors in chronic kidney disease. Clin Exp Immunol 2016;186:86-95. [PMID: 27414487 DOI: 10.1111/cei.12844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Rangel-López A, Paniagua-Medina ME, Urbán-Reyes M, Cortes-Arredondo M, Alvarez-Aguilar C, López-Meza J, Ochoa-Zarzosa A, Lindholm B, García-López E, Paniagua JR. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study. Mutagenesis 2013;28:219-25. [PMID: 23408844 DOI: 10.1093/mutage/ges075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
42 Li X, Kshirsagar AV, Brookhart MA. Safety of intravenous iron in hemodialysis patients. Hemodial Int 2017;21 Suppl 1:S93-S103. [PMID: 28370957 DOI: 10.1111/hdi.12558] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
43 Shiotsu Y, Mori Y, Nishimura M, Hatta T, Imada N, Maki N, Iida K, Iwamoto N, Matsuoka E, Tamagaki K, Kosaki A. Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan. BMC Nephrol 2013;14:16. [PMID: 23324110 DOI: 10.1186/1471-2369-14-16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
44 Runesson B, Qureshi AR, Xu H, Gasparini A, Lindholm B, Barany P, Elinder CG, Carrero JJ. Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project. PLoS One 2019;14:e0209440. [PMID: 30650090 DOI: 10.1371/journal.pone.0209440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Asgharpour M, Alirezaei A. Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications. Ren Fail 2021;43:351-61. [PMID: 33593237 DOI: 10.1080/0886022X.2021.1880939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Liakopoulos V, Roumeliotis S, Gorny X, Eleftheriadis T, Mertens PR. Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature. Oxid Med Cell Longev 2017;2017:3494867. [PMID: 29750088 DOI: 10.1155/2017/3494867] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
47 Song YR, Kim JK, Lee HS, Kim SG, Choi EK. Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients. BMC Nephrol 2020;21:281. [PMID: 32677905 DOI: 10.1186/s12882-020-01937-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
48 Popkov VA, Silachev DN, Zalevsky AO, Zorov DB, Plotnikov EY. Mitochondria as a Source and a Target for Uremic Toxins. Int J Mol Sci 2019;20:E3094. [PMID: 31242575 DOI: 10.3390/ijms20123094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
49 Blatt NB, Srinivasan S, Mottes T, Shanley MM, Shanley TP. Biology of sepsis: its relevance to pediatric nephrology. Pediatr Nephrol. 2014;29:2273-2287. [PMID: 24408224 DOI: 10.1007/s00467-013-2677-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]